Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06336681 · ClinicalTrials.gov registry record · NA

Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT06336681 is a NA study that has completed, run by Indiana University. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06336681, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Due to the lack of studies examining the impact of inspiratory muscle training (IMT) on the severity of exercise-induced bronchoconstriction (EIB) and exercise performance, the specific aim of this study is to assess the efficacy of flow-resistive IMT on EIB severity and symptoms, short-acting beta-2-agonist medication use, operating lung volumes, respiratory and limb locomotor muscle deoxygenation during constant-load cycling exercise, exertional dyspnea, and cycling time-trial performance.

Interventions

  • DEVICE PrO2Fit Device

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-02-10
Est. Completion 2025-04-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06336681

The ClinicalTrials.gov registry entry for NCT06336681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PrO2Fit Device is the first listed.

NCT06336681 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06336681 about?

NCT06336681 is a clinical study titled "Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)". Due to the lack of studies examining the impact of inspiratory muscle training (IMT) on the severity of exercise-induced bronchoconstriction (EIB) and exercise performance, the specific aim of this study is to assess the efficacy of flow-resistive IMT on EIB severity and symptoms, short-acting beta-...

What is the current status of trial NCT06336681?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-02-10. Estimated completion is 2025-04-30.

What interventions are being tested in trial NCT06336681?

The interventions under investigation include: PrO2Fit Device (DEVICE).

Who is sponsoring clinical trial NCT06336681?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.